EyePoint Pharmaceuticals Inc (EYPT)
10.49
-0.27
(-2.51%)
USD |
NASDAQ |
Nov 14, 16:00
10.48
-0.01
(-0.10%)
After-Hours: 20:00
EyePoint Pharmaceuticals Gross Profit (Annual): 41.39M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 41.39M |
December 31, 2022 | 33.08M |
December 31, 2021 | 28.76M |
December 31, 2020 | 28.61M |
December 31, 2019 | 17.68M |
December 31, 2018 | 2.928M |
June 30, 2018 | 2.961M |
June 30, 2017 | 7.539M |
June 30, 2016 |
Date | Value |
---|---|
June 30, 2015 | |
June 30, 2014 | |
June 30, 2013 | |
June 30, 2012 | |
June 30, 2011 | |
June 30, 2010 | 23.05M |
June 30, 2009 | 12.16M |
June 30, 2008 | 3.476M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
17.68M
Minimum
2019
41.39M
Maximum
2023
29.90M
Average
28.76M
Median
2021
Gross Profit (Annual) Benchmarks
Cassava Sciences Inc | -- |
Regeneron Pharmaceuticals Inc | 11.30B |
Adverum Biotechnologies Inc | -- |
Regenxbio Inc | 53.03M |
Editas Medicine Inc | -- |